Bank Of Montreal Biolife Solutions Inc Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$17.19 - $24.34 $156,721 - $221,907	9,117 New	9,117 $201,000
Q1 2023 Jun 13, 2024	BUY	$17.67 - $26.07 $194,988 - $287,682	11,035 New	11,035 $240,000
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $139,533 - $254,477	9,531 New	9,531 $229,000
Q2 2022 Aug 11, 2022	SELL	$10.54 - $24.2 $98,169 - $225,398	-9,314 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$20.81 - $37.29 $4,765 - $8,539	229 Added 2.52%	9,314 $215,000
Q4 2021 Feb 11, 2022	SELL	$32.99 - $58.55 $3.75 Million - $6.66 Million	-113,788 Reduced 92.61%	9,085 $341,000
Q3 2021 Nov 12, 2021	SELL	$42.03 - $60.5 $284,164 - $409,040	-6,761 Reduced 5.22%	122,873 $5.28 Million
Q2 2021 Aug 12, 2021	BUY	$29.51 - $44.62 $3.83 Million - $5.78 Million	129,634 New	129,634 $5.86 Million

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.